Platelet monoamine oxidase inhibition by deprenyl and tranylcypromine: implications for clinical use.
D001792:Blood Platelets / Q000187:drug effects / Q000201:enzymology; D003866:Depressive Disorder / Q000188:drug therapy* / Q000201:enzymology; D004305:Dose-Response Relationship, Drug; D006801:Humans; D008995:Monoamine Oxidase / Q000097:blood*; D010627:Phenethylamines / Q000627:therapeutic use*; D012642:Selegiline / Q000627:therapeutic use*; D014191:Tranylcypromine / Q000627:therapeutic use*
D010627:Phenethylamines; D012642:Selegiline; D014191:Tranylcypromine; D008995:Monoamine Oxidase